1. Health

Interstitial Lung Disease Market Share, Strategies, Growth Demand, Outlook, Scope By 2033

Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Overview and Scope
Interstitial lung disease (ILD) refers to lung conditions that affect the interstitium, the tissue and the area surrounding the alveoli in the lungs. The interstitium is essential for maintaining the structural integrity and function of the lungs, as it supports gas exchange between the lungs and the bloodstream.

Sizing and Forecast
The interstitial lung disease market size has grown strongly in recent years. It will grow from $1.83 billion in 2023 to $1.97 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%.  The  growth in the historic period can be attributed to awareness and diagnosis improvement, immune system modulation therapies, respiratory rehabilitation programs, multidisciplinary care teams.

The interstitial lung disease market size is expected to see strong growth in the next few years. It will grow to $2.62 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.  The growth in the forecast period can be attributed to precision medicine, novel drug development, regenerative medicine, telehealth and remote monitoring. Major trends in the forecast period include advancements in imaging technology, ai in imaging, fibrosis subtype differentiation, supportive care services.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report

Segmentation & Regional Insights
The interstitial lung disease market covered in this report is segmented –
1) By Drug Type: Oral Corticosteroids; Immune Suppressing; Anti-Fibrotic Medication; Other Drugs
2) By Disease Type: Interstitial Pneumonia; Idiopathic Pulmonary Fibrosis; Nonspecific Interstitial Pneumonitis; Hypersensitivity Pneumonitis; Cryptogenic Organizing Pneumonia (COP); Sarcoidosis; Acute Interstitial Pneumonitis
3) By Application: Adults; Children
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

North America was the largest region in the interstitial lung disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interstitial lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13019&type=smp

Major Driver Impacting Market Growth
The growing prevalence of allergic conditions is expected to propel the growth of the interstitial lung disease market going forward. An allergic condition is when the immune system overreacts to an allergen, often known as a harmless substance. Allergic reactions might result in interstitial lung disease (ILD), specifically hypersensitivity pneumonitis, which causes an allergic reaction in the body causes hypersensitivity pneumonitis. For instance, in January 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency for public health, over one-third of American adults and more than one-fourth of American children had a seasonal allergy, eczema, or food allergy in 2021. Further, anaphylaxis (a severe allergic reaction to food) is estimated to cause 90,000 emergency room visits in the United States each year. Therefore, the growing prevalence of allergic conditions is driving the growth of the interstitial lung disease market.

Key Industry Players
Major players in the interstitial lung disease market are  Roche Laboratories Inc., Merck & Co. Inc., Bayer AG, Novartis Pharmaceuticals Corporation, The Bristol-Myers Squibb Company, Amgen Inc., Boehringer Ingelheim, Siemens Healthineers, Koninklijke Philips N.V., Teva Pharmaceuticals USA Inc., AstraZeneca PLC, Horizon Pharma USA Inc., Genentech Inc., Amneal Pharmaceuticals LLC, Fujirebio Diagnostics Inc., Insmed Inc., VIDA Diagnostics Inc., EmphyCorp Inc., Verseau Therapeutics, Regend Therapeutics Co., LTT Bio-Pharma Co. Ltd., Galecto Biotech, Pulmatrix Inc., PureTech Health PLC, Pneuma Respiratory Inc., Bellerophon Therapeutics Inc., MediciNova Inc., Altavant Sciences Inc., Verona Pharma plc.

The interstitial lung disease market report table of contents includes:
1. Executive Summary

  1. Interstitial Lung Disease Market Characteristics
  2. Interstitial Lung Disease Market Trends And Strategies
  3. Interstitial Lung Disease Market – Macro Economic Scenario
  4. Global Interstitial Lung Disease Market Size and Growth
  5. Interstitial Lung Disease Market Segmentation
  6. Interstitial Lung Disease Market Regional And Country Analysis

…………..                     

  1. Key Mergers And Acquisitions In The Interstitial Lung Disease Market
  2. Interstitial Lung Disease Market Future Outlook and Potential Analysis
  3. Appendix

List Of Tables : 

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Interstitial Lung Disease Market, Segmentation By Drug Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Interstitial Lung Disease Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Interstitial Lung Disease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

…………….

Table 75: Roche Laboratories Inc. Financial Performance

Table 76: Merck & Co. Inc. Financial Performance

Table 77: Bayer AG Financial Performance

Table 78: Novartis Pharmaceuticals Corporation Financial Performance

Table 79: The Bristol-Myers Squibb Company Financial Performance


Explore the trending research reports from TBRC:

https://topprnews.com/diverticulitis-disease-market-major-players/

https://goodprnews.com/medical-specialty-bags-market-growth/

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe